Saturday, December 7, 2024

Genpact Named Leader in 2024 Life Sciences Digital Services

Related stories

Alibaba Launches ‘Pic Copilot’ AI E-Commerce Tool

Alibaba International Digital Commerce Group is excited to announce...

Tractian Secures $120M to Reduce Industrial Downtime

Led by Sapphire Ventures, the round will enable Tractian...

Unisys Appoints Michael M. Thomson as CEO

The Unisys Board of Directors announced that it unanimously elected...

Veritone Expands Enterprise AI Solutions

Veritone, Inc, a leader in designing human-centered AI solutions,...
spot_imgspot_img

Recognition highlights Genpact’s commitment to delivering personalized support and innovative solutions to mid-market life sciences organizations

Genpact, a global professional services and solutions firm delivering outcomes that shape the future, has been named a Leader in Everest Group’s inaugural Life Sciences Digital Services for Mid-Market Enterprises 2024 PEAK Matrix® Assessment. This recognition is a testament to Genpact’s deep industry expertise and significant market impact in delivering innovative and cost-effective solutions and services to mid-market life sciences companies.

“Amid economic uncertainty, disrupted supply chains, and high customer expectations, it’s more important than ever for life sciences companies to focus on AI innovation and operational resilience,” said Sanjiv Tandon, Global Business Unit Leader, Life Sciences, Genpact. “Our deep industry expertise and customer-centric approach have made us a trusted partner in delivering transformative outcomes, and this leadership recognition validates our commitment to improving global health by accelerating the time-to-market for drugs and devices.”

Everest Group assessed 26 life sciences digital services providers around the globe based on their vision, capability, and market impact.

Also Read: Debiopharm & WhiteLab Partner to Advance Oncology Drug Design

Genpact’s leadership is underpinned by its excellence in delivering key services, including:

  • Data Analytics and Insights: Leveraging AI-powered analytics to help life sciences companies uncover valuable insights for better decision-making, Genpact’s digital solutions help improve patient experiences and outcomes, optimize sales strategies, and enhance marketing efforts.
  • Supply Chain Resilience: In an industry where integrated sales and operations planning is critical, Genpact’s supply chain management solutions and services optimize the entire value chain, from forecasting and network design to transportation and logistics, mitigating supply chain risks and improving operational efficiency.
  • Regulatory Compliance: The regulatory landscape for life sciences continues to evolve, and compliance is essential. Genpact’s regulatory affairs services help companies navigate regulatory complexity and compliance.
  • Patient-Centric Experiences: With the shift towards patient-centric models, Genpact’s advanced analytics and AI-driven customer experience solutions and expertise in digital therapeutics help companies enhance patient engagement, improve adherence, and deliver better health outcomes.

“Mid-market life sciences enterprises face unique challenges that distinguish them from their larger counterparts, necessitating distinct sourcing needs such as client intimacy, agility, and cost-effective innovation to stay competitive. Recognizing these specific needs, providers are tailoring their strategies to offer personalized support and innovative solutions, capitalizing on the increasing mid-market demand,” said Durga Ambati, Practice Director, Everest Group. “Genpact‘s ability to creatively engage clients in strategic conversations, complemented by its willingness to explore innovative commercial constructs, has helped it to establish a global client presence and be recognized as a Leader in Everest Group’s Life Sciences Digital Services for Mid-market Enterprises PEAK Matrix® Assessment 2024.”

Source: PRNewswire

Subscribe

- Never miss a story with notifications


    Latest stories

    spot_img